Pharvaris
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pharvaris and other ETFs, options, and stocks.About PHVS
Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases.
CEOBerndt A. E. Modig
CEOBerndt A. E. Modig
Employees108
Employees108
HeadquartersLeiden, Zuid-Holland
HeadquartersLeiden, Zuid-Holland
Founded2015
Founded2015
Employees108
Employees108
PHVS Key Statistics
Market cap1.38B
Market cap1.38B
Price-Earnings ratio-8.32
Price-Earnings ratio-8.32
Dividend yield—
Dividend yield—
Average volume49.40K
Average volume49.40K
High today$25.76
High today$25.76
Low today$19.98
Low today$19.98
Open price$20.00
Open price$20.00
Volume154.96K
Volume154.96K
52 Week high$25.76
52 Week high$25.76
52 Week low$11.51
52 Week low$11.51
Analyst ratings
91%
of 11 ratingsBuy
90.9%
Hold
0%
Sell
9.1%
People also own
Based on the portfolios of people who own PHVS. This list is generated using Robinhood data, and it’s not a recommendation.